IP Library › Granted Patent US 9,663,555
Granted Patent B2
US 9,663,555 · App. 15/234,036 · Granted May 30, 2017

Beta sheet tapes ribbons in tissue engineering

Inventors: Neville Boden (Leeds, GB); Amalia Aggeli (Thessaloniki, GR); Eileen Ingham (Leeds, GB); Jennifer Kirkham (Leeds, GB)
Assignee: University of Leeds
C07K14/001A61K6/0002A61K6/02A61K6/08A61K8/042A61K8/64A61K47/42A61K47/48246A61K47/48784A61L27/22A61L27/227A61L27/38A61L27/50A61L27/54A61L27/56A61Q5/00A61Q19/00C07K7/06C12N5/0068A61K2800/40A61L2300/412A61L2430/02C12N2533/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,663,555
App. No.
15/234,036
Granted
May 30, 2017
Kind
B2
Abstract

There is described a material comprising tapes, ribbons, fibrils or fibers characterized in that each of the ribbons, fibrils or fibers have an antiparallel arrangement of peptides in a β-sheet tape-like substructure wherein the material comprises a pair of self assembling complementary polypeptides.

Claims (19)

1. A pair of self assembling complementary polypeptides (SACPs) that form tapes, ribbons, fibrils or fibres in a β-sheet tape-like substructure, when a first monomeric peptide is contacted or mixed with its complementary monomeric peptide and wherein the SACPs comprise P 11 -30/31 (SEQ ID NOs: 8 and 9).

2. The SACPs of claim 1 , further comprising a bioactive peptide or a therapeutically active molecule conjugated to the SACPs.

3. A composition, comprising:

tapes, ribbons, fibrils or fibres, wherein each of the tapes, ribbons, fibrils or fibres has an antiparallel arrangement of SACPs in a β-sheet tape-like substructure, wherein the SACPs comprise P 11 -30/31 (SEQ ID NOs: 8 and 9).

4. The composition of claim 3 , wherein the composition comprises SACPs which form ribbons and/or fibrils immediately when a first monomeric peptide contacts a second complementary monomeric peptide.

5. The composition of claim 3 , wherein the SACPs further comprise a bioactive peptide or a therapeutically active molecule conjugated to the SACPs.

6. The composition of claim 3 , wherein the composition comprises fibrils, and wherein the fibrils are comprised in a network of fibrils interconnected at fibre-like junctions.

7. A dental product comprising the composition of claim 3 .

8. The dental product of claim 7 , wherein the dental product is a dental repair, dental treatment, or dental reconstruction product.

9. The composition of claim 3 , wherein the composition is in the form of a tissue engineering scaffold.

10. The composition of claim 9 , wherein the scaffold is seeded with cells.

11. The composition of claim 3 , wherein the composition is part of a bioresponsive and biocompatible surface.

12. The composition of claim 3 , wherein the composition is a template for nucleation and growth of inorganic materials.

13. The composition of claim 3 , wherein the composition comprises a continuous filament yarn, staple, floc, cord, or fabric.

14. A tissue repair product comprising the composition of claim 3 .

15. A wound healing product comprising the composition of claim 3 .

16. A skin treatment product comprising the composition of claim 3 .

17. A hair care product comprising the composition of claim 3 .

18. A bone reconstruction product comprising the composition of claim 3 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2021
From: UNIVERSITY OF LEEDS
To: CREDENTIS A.G.
Reel/Frame 055483/0847 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2016
From: BODEN, NEVILLE; AGGELI, AMALIA; INGHAM, EILEEN; KIRKHAM, JENNIFER
To: UNIVERSITY OF LEEDS
Reel/Frame 039401/0468 →
Priority Claims (1)
GB 0216286.5 · Jul 15, 2002 · national
Continuity (6)
Division 15066818 · Mar 10, 2016
Division 14791622 · Jul 6, 2015
Division 13551878 · Jul 18, 2012
Continuation In Part 12729046 · Mar 22, 2010
Continuation In Part 10521628
Related Publication 20160340392A1 · Nov 24, 2016